Melatonin, Night Shift Work, and DNA Repair: Promising Signal, Not a Longevity Shortcut
Melatonin is usually discussed as a sleep supplement. But a small randomized clinical trial in night-shift workers suggests it may also support one of the body’s quiet repair systems: oxidative DNA damage repair during daytime sleep.
That is interesting. It is also easy to overstate.
This study does not prove that melatonin prevents cancer. It does not prove that night-shift work becomes harmless if you take a supplement. And it does not turn melatonin into a magic longevity compound.
What it does suggest is more nuanced and more clinically useful: when the body’s normal circadian rhythm is disrupted by overnight work, restoring part of the melatonin signal may help support repair biology during the recovery sleep window.
AI Overview: A small randomized placebo-controlled trial found that night-shift workers who took 3 mg of melatonin before daytime sleep had higher urinary levels of 8-OHdG, a marker interpreted as improved oxidative DNA damage repair activity. The finding is promising, but it is not proof that melatonin prevents cancer or eliminates the risks of circadian disruption. At HormoneSynergy®, we view melatonin as one possible tool within a larger sleep, light, metabolic, and longevity strategy.
What the Study Found
The trial included 40 night-shift workers who had been working at least two consecutive night shifts per week for at least six months. Half took 3 mg of melatonin about one hour before going to sleep during the day after night work. The other half took placebo. The intervention lasted four weeks.
The researchers measured urinary 8-OHdG, a marker used to assess oxidative DNA damage repair capacity. In the melatonin group, urinary 8-OHdG levels were significantly higher during daytime sleep compared with placebo. That suggests melatonin may have helped support DNA repair activity while the workers were sleeping after overnight shifts.
Importantly, the same effect was not clearly seen during the following night shift. The signal appeared during the daytime sleep recovery window, not across all periods of work and wakefulness.
Why Night-Shift Work Is Biologically Stressful
Night-shift work is not simply “being awake at a different time.” It changes the relationship between light, darkness, sleep, cortisol rhythm, melatonin signaling, glucose regulation, immune function, appetite, and repair biology.
The body is designed to coordinate many repair processes with darkness and sleep. When someone works under artificial light at night and sleeps during daylight hours, the normal timing signals can become blurred. Melatonin production may be suppressed. Sleep may be shorter or less restorative. Meals may happen at biologically mismatched times. Metabolic and inflammatory patterns can shift.
This is why long-term night-shift work has been studied in relation to cardiometabolic risk, sleep disruption, mood changes, and cancer biology. The International Agency for Research on Cancer has classified night-shift work as probably carcinogenic to humans, based on a combination of human, animal, and mechanistic evidence.
That does not mean every night-shift worker will develop cancer. It means the biology deserves respect.
Melatonin Is a Signal, Not Just a Sleep Aid
Melatonin is often treated casually, as if it were simply a natural sleeping pill. That is too simplistic.
Melatonin is a hormone-like circadian signal. It rises in darkness and helps tell the body that it is time for rest, repair, and nighttime physiology. It also interacts with oxidative stress pathways, mitochondrial function, immune signaling, and cellular repair mechanisms.
That is why this study is interesting. The benefit may not be only about “falling asleep faster.” It may be about restoring a missing biological signal in people whose work schedule suppresses that signal.
But more biology is not the same as more benefit. Dose, timing, duration, individual response, light exposure, medications, age, hormone status, and underlying health all matter.
What This Study Does Not Prove
This is where the headline needs discipline.
The study does not prove that melatonin prevents cancer. It did not measure cancer outcomes. It did not follow people for years. It did not compare different doses. It did not prove long-term safety or long-term benefit for every night-shift worker.
It measured a biomarker related to oxidative DNA damage repair capacity over four weeks in a small group of workers.
That is still meaningful. Biomarkers can help us understand mechanisms. But a biomarker is not the same as a clinical outcome.
At HormoneSynergy®, this is the kind of study we take seriously without turning it into a sales pitch. It is a signal. It is not a shortcut.
The Bigger Longevity Lesson: Protect the Circadian System
If you work nights, melatonin may eventually prove to be one useful tool. But the larger strategy should focus on protecting circadian health as much as possible.
That includes reducing bright light exposure before daytime sleep, making the sleep environment dark and cool, protecting sleep duration, avoiding heavy meals during the biological night when possible, maintaining consistent sleep timing when your schedule allows, and paying attention to glucose, blood pressure, lipids, inflammation, and body composition over time.
Night-shift workers often carry a higher burden because they are fighting biology to serve others: nurses, physicians, first responders, caregivers, security workers, transportation workers, manufacturing teams, and many others. The answer is not shame. The answer is better support.
Melatonin may help restore part of the darkness signal. But it cannot replace sleep opportunity, circadian hygiene, metabolic health, or medical follow-up.
Where Melatonin May Fit
For some people, especially those sleeping during the day after night work, low-dose melatonin taken at the right time may help reinforce the sleep-and-repair window.
For others, melatonin may cause grogginess, vivid dreams, mood changes, morning sedation, or poor timing effects. It may also interact with certain medications or be inappropriate in some clinical situations. More is not automatically better.
For patients who already work with HormoneSynergy® Clinic, this is the kind of supplement question we prefer to place in context: sleep schedule, light exposure, hormone status, glucose regulation, cardiometabolic risk, medications, and the reason for using it.
For those looking for a simple 3 mg option, RetzlerRx® Melatonin 3 mg may be considered as part of a broader sleep and circadian support plan. It should not be viewed as a stand-alone longevity treatment or as protection from the long-term effects of chronic circadian disruption.
Medicine, Not Marketing
The wellness internet loves turning a study like this into a miracle claim: “Melatonin repairs DNA.” That is not how we would say it.
A more responsible interpretation is this: a small clinical trial suggests that melatonin supplementation before daytime sleep may improve a marker of oxidative DNA damage repair capacity in night-shift workers. That finding deserves attention, especially because night-shift work is a real biological stressor.
But good medicine does not confuse early evidence with certainty. It asks better questions.
Who benefits most? What dose is best? How long is it safe to use? Does timing matter more than dose? Does light exposure change the result? Does improved repair-marker activity translate into lower long-term disease risk? Are there subgroups who should avoid it?
Those are the questions that matter.
HormoneSynergy® Perspective
Melatonin is not just a sleep supplement. It is part of a larger circadian conversation.
For night-shift workers, the goal should not be to use melatonin to override biology. The goal should be to reduce the biological cost of a difficult schedule wherever possible.
That means protecting sleep, managing light, maintaining metabolic health, evaluating cardiovascular risk, supporting hormone balance when clinically appropriate, and using supplements thoughtfully rather than reactively.
Melatonin may be helpful. It may even prove to have a meaningful role in night-shift recovery biology. But it should be used with the same restraint we bring to every longevity intervention.
Promising signal. Not a shortcut. Useful tool. Not a free pass.
Related HormoneSynergy® Resources
For more on sleep, recovery, brain health, and longevity medicine, visit our Sleep and Recovery in Longevity Medicine page and our Brain Health, Sleep & Mood Support collection.
Frequently Asked Questions
Does this study prove melatonin prevents cancer?
No. The study measured a biomarker related to oxidative DNA damage repair capacity. It did not measure cancer outcomes or prove cancer prevention.
Why would melatonin matter for night-shift workers?
Night-shift work can suppress normal nighttime melatonin signaling and disrupt circadian rhythm. Melatonin may help restore part of the darkness-and-sleep signal during daytime recovery sleep.
Is 3 mg the right melatonin dose for everyone?
No. The study used 3 mg, but the best dose may vary by person, timing, sleep schedule, medications, and clinical context. More is not always better.
Should every night-shift worker take melatonin?
Not necessarily. Melatonin may be useful for some people, but it should be considered in the context of sleep timing, light exposure, medical history, medication use, and overall health risk.
What matters besides melatonin?
Sleep duration, darkness during daytime sleep, light management, meal timing, glucose regulation, blood pressure, inflammation, body composition, and cardiovascular risk all matter for long-term health in night-shift workers.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →